| http://www.w3.org/ns/prov#value | - aspirin (> 325 mg/day)More than 14 days since prior targeted small molecule anticancer agentsMore than 28 days since prior investigational or antineoplastic agents except hydroxyurea or anagrelideAt least 5 days or 5 half-lives (whichever is greater) since prior and no concurrent drugs that carry a risk of causing torsades de Pointes, including any of the following:QuinidineProcainamideDisopyrami
|
